Chevron Corporation’s (CVX Quick QuoteCVX ) subsidiary Chevron U.S.A. Inc. recently inked agreements with one of the world’s leading integrated energy and commodities firms Mercuria Energy Trading (Mercuria) to form a joint venture (JV). The new JV will buy American Natural Gas LLC (ANG), a Saratoga Springs, New York-based company, which operates 60 compressed natural gas (CNG) stations across the United States.
The transaction is part of Chevron’s attempt to develop a large-scale, vertically integrated renewable natural gas business in America. The company is developing projects to create renewable natural gas from cow manure across the country through partnerships with Brightmark and California Bioenergy. The integrated energy firm will be able to swiftly expand its renewable natural gas value chain, courtesy of this joint venture, which will complement its previously announced plan to open more than 30 Chevron-branded CNG stations by 2025.
Top 5 Value Stocks To Buy Right Now: Kelly Services Inc.(KELYA)
Kelly Services, Inc., together with its subsidiaries, provides workforce solutions to various industries worldwide. The company offers trained employees who work in word processing, data entry, and as administrative support staff; staff for contact centers, technical support hotlines, and telemarketing units; substitute teachers; support staff for seminars, sales, and trade shows; technicians for the technology, aerospace, and pharmaceutical industries; maintenance workers, material handlers, and assemblers; and temporary and full-time placement services, as well as direct-hire placement and vendor on-site management services. It also provides scientific and clinical research workforce solutions; chefs, porters, and hospitality representatives; manual workers to semi-skilled professionals in trade, non-trade, and operational positions; engineering professionals for various disciplines, such as aeronautical, chemical, civil/structural, electrical/instrumentation, environmen tal, industrial, mechanical, petroleum, pharmaceutical, quality, and telecommunications; and employees for creative services positions. In addition, the company offers professionals for corporate finance departments, accounting firms, and financial institutions; talent management solutions; healthcare specialists and professionals for hospitals, ambulatory care centers, HMOs, and other health insurance companies; information technology specialists; legal professionals, such as attorneys, paralegals, contract administrators, compliance specialists, and legal administrators; and mid- to senior-level search and selection services, as well as consulting services. Further, it provides recruitment process and contingent workforce outsourcing, independent contractor solutions, payroll and business process outsourcing, career transition and organizational effectiveness, and executive search services. The company was founded in 1946 and is headquartered in Troy, Michigan.
- [By Shane Hupp]
Get a free copy of the Zacks research report on Kelly Services (KELYA)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Ethan Ryder]
BidaskClub downgraded shares of Kelly Services (NASDAQ:KELYA) from a strong-buy rating to a buy rating in a report released on Wednesday morning.
KELYA has been the subject of a number of other research reports. ValuEngine lowered shares of Kelly Services from a hold rating to a sell rating in a research note on Monday, February 4th. Zacks Investment Research raised shares of Kelly Services from a hold rating to a buy rating and set a $25.00 target price for the company in a research note on Tuesday, February 5th. Finally, TheStreet lowered shares of Kelly Services from a b rating to a c+ rating in a research note on Thursday, February 14th. Two investment analysts have rated the stock with a sell rating and three have given a buy rating to the stock. The company presently has an average rating of Hold and an average target price of $32.00.
Top 5 Value Stocks To Buy Right Now: Marlin Business Services Corp.(MRLN)
Marlin Business Services Corp., incorporated on August 5, 2003, is a provider of equipment financing solutions primarily to small and mid-sized businesses. The Company finances over 100 categories of common-use commercial equipment. The Company accesses its end user customers primarily through origination sources, including its existing network of over 12,300 independent commercial equipment dealers and various national account programs; through direct solicitation of its end user customers, and through relationships with select lease brokers. The Company provides equipment dealers with the ability to offer its lease financing and related services to their customers as an integrated part of their selling process. The Company’s integrated account origination platform enables it to solicit, process and service various low-balance financing transactions.
The Company’s subsidiary, Marlin Business Bank (MBB), serves as the Company’s primary funding source, through the issuance of Federal Deposit Insurance Corporation (FDIC)-insured deposits and FDIC-insured money market deposit accounts. The Company’s product offerings include equipment leases, property insurance on leased equipment, and funding stream. Its equipment leases provide for non-cancelable rental payments due during the initial lease term. Its Funding Stream is a loan program of MBB. The Company has approximately 82,000 active leases in its portfolio. The Company’s financed equipment categories include copiers, commercial and industrial, computer software, restaurant, telecommunications equipment, computers, closed circuit television security systems, cash registers, security systems, dishmachines and auto equipment. The Company’s customers are located in various states of the United States, such as California, Texas, New York, New Jersey, Georgia, Ohio and Virginia, and the District of Columbia.
- [By Max Byerly]
Marlin Business Services (NASDAQ:MRLN) and MID-SOUTHERN Sv/SH (OTCMKTS:MSVB) are both small-cap finance companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk and institutional ownership.
- [By Ethan Ryder]
TIAA CREF Investment Management LLC reduced its position in Marlin Business Services Corp. (NASDAQ:MRLN) by 12.5% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 17,342 shares of the financial services provider’s stock after selling 2,468 shares during the quarter. TIAA CREF Investment Management LLC owned about 0.14% of Marlin Business Services worth $500,000 at the end of the most recent reporting period.
Top 5 Value Stocks To Buy Right Now: Alcatel Lucent(ALU)
Altium Limited is engaged in the development and sales of computer software for the design of electronic products. The Company’s products include Altium Designer and TASKING. The Company’s segments include Board and Systems, Micro-controllers and Embedded Systems, Makers and Content, and Other Segments. The Board and Systems segment includes results from printed circuit board (PCB) business for the Americas, Europe, the Middle East and Africa (EMEA), Asia Pacific and Emerging Markets regions, as well as other products sold through partner channels. The Emerging Markets region includes results from PCB business for the China, Russia and India regions. The Micro-controller and Embedded Systems segment includes results from TASKING sales, operations and research and development. The Makers and Content segment includes the results from Octopart. Its products and services include software and hardware, subscription services, training services, project services and search advertising. Advisors’ Opinion:
- [By Joseph Griffin]
In related news, insider Sergiy Kostynsky 250,000 shares of the business’s stock in a transaction dated Monday, November 26th. Also, insider Lynn Mickleburgh acquired 6,800 shares of Altium stock in a transaction that occurred on Friday, December 28th. The shares were bought at an average price of A$14.74 ($10.45) per share, for a total transaction of A$100,232.00 ($71,086.52).
ILLEGAL ACTIVITY NOTICE: “Altium Limited Announces Interim Dividend of $0.16 (ALU)” was reported by Ticker Report and is the sole property of of Ticker Report. If you are viewing this piece on another domain, it was copied illegally and republished in violation of United States & international copyright & trademark law. The correct version of this piece can be accessed at www.tickerreport.com/banking-finance/4164167/altium-limited-announces-interim-dividend-of-0-16-alu.html.
- [By Joseph Griffin]
Press coverage about Alcatel Lucent (NYSE:ALU) has been trending positive on Monday, according to Accern Sentiment. The research group ranks the sentiment of news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Alcatel Lucent earned a news sentiment score of 0.27 on Accern’s scale. Accern also assigned headlines about the communications equipment provider an impact score of 48.5554072096128 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.
- [By Ethan Ryder]
Media coverage about Alcatel Lucent (NYSE:ALU) has been trending somewhat positive this week, Accern reports. The research group identifies negative and positive news coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Alcatel Lucent earned a media sentiment score of 0.08 on Accern’s scale. Accern also gave headlines about the communications equipment provider an impact score of 45.9413628150958 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.
Top 5 Value Stocks To Buy Right Now: Blueprint Medicines Corporation(BPMC)
Blueprint Medicines Corporation, a biopharmaceutical company, focuses on the development of the highly selective kinase inhibitors for genomically defined cancer subsets. The companys lead drug candidates include BLU-285, which targets KIT Exon 17 and PDGFRa D842V, abnormally active receptor tyrosine kinase mutants for patients with systemic mastocytosis, a myeloproliferative disorder of the mast cells, and defined subsets of patients with gastrointestinal stromal tumor, as well as targets the KIT D816V mutation; and BLU-554, an orally available, potent, selective, and irreversible inhibitor, which targets FGFR4. It is also developing a drug candidate to target RET, a receptor tyrosine kinase that can becomes abnormally activated when a portion of the gene that encodes RET is joined to part of another gene; and RET resistant mutants that would arise from treatment with first generation therapies, as well as a program that targets rare genetic diseases. The company has a research, development, and commercialization agreement with Alexion Pharma Holding to research, develop, and commercialize drug candidates for an undisclosed activated kinase target, which is the cause of a rare genetic disease. The company was formerly known as Hoyle Pharmaceuticals, Inc. and changed its name to Blueprint Medicines Corporation in June 2011. Blueprint Medicines Corporation was founded in 2008 and is based in Cambridge, Massachusetts.
- [By Alexander Bird]
Here are last week’s top-performing penny stocks:
Penny Stock Current Share Price Last Week’s Gain
Ambow Education Holdings Ltd. (NYSE: AMBO) $5.70 77.11%
Nano Dimension (Nasdaq: NNDM) $2.61 75.11%
Destination Maternity Corp. (Nasdaq: DEST) $5.79 71.84%
CLPS Inc. (Nasdaq: CLPS) $9.72 71.15%
NII Holdings Inc. (Nasdaq: NIHD) $3.20 56.33%
Viveve Medical Inc. (Nasdaq: VIVE) $3.78 51.98%
Galectin Therapeutics Inc. (Nasdaq: GALT) $9.18 41.82%
Apricus Biosciences Inc. (Nasdaq: APRI) $0.36 34.70%
Polymet Mining Corp. (NYSE: PLM) $1.01 31.13%
Xenon Pharmaceuticals Inc. (Nasdaq: XENE) $8.20 28.46%
Many investors struggle with finding stocks with this sort of breakout potential because they don’t know where to look.
- [By Paul Ausick]
Apricus Biosciences Inc. (NASDAQ: APRI) also dropped about 38% Monday to post a new 52-week low of $0.26. Shares closed at $0.42 on Friday and the stock’s 52-week high is $3.34. Volume was more than three times the daily average of around 1.4 million shares. The company is considering its options after the U.S. FDA directed the firm to develop a new formulation for its erectile dysfunction drug, Vitaros.
- [By William Romov]
California-based Apricus Biosciences Inc. (Nasdaq: APRI) develops treatments in the areas of urology and rheumatology. Its lead product, Vitaros, is a topically applied cream for the treatment of erectile dysfunction (ED).
- [By Chris Lange]
Apricus Biosciences Inc. (NASDAQ: APRI) has a PDUFA goal date for completion of the FDA’s review of the Vitaros NDA set on February 17. Vitaros is a novel, on-demand topical cream for the treatment of erectile dysfunction (ED) and a new potential entrant into the U.S. ED treatment market. So far Vitaros has been approved in Canada, Mexico and certain countries in Europe, Latin America and the Middle East. Shares of Apricus were last seen at $2.22, with a 52-week range of $0.86 to $3.49 and a consensus price target of $3.50.